07:20:34 EDT Tue 28 Apr 2026
Enter Symbol
or Name
USA
CA



Nirvana Life Sciences Inc (2)
Symbol NIRV
Shares Issued 4,823,301
Close 2026-02-26 C$ 0.005
Market Cap C$ 24,117
Recent Sedar+ Documents

Nirvana extends 370,000 warrants to 2027

2026-04-28 04:10 ET - News Release

Subject: NIRV News Release PDF Document

File: Attachment NR 28-04-26 AGM WARRANT.pdf

NIRVANA ANNOUNCES EXTENSION OF WARRANTS

VANCOUVER, B.C. April 28, 2026 (NEWSFILE) - Nirvana Life Sciences Inc., (CSE:NIRV) ("Nirvana" or the "Company") announces that it intends to amend the terms of a total of 370,000 share purchase warrants (the "Warrants") having a current exercise price of $0.25 per share. The Warrants were issued by the Company on or about May 25, 2022 and May 25, 2023, with each Warrant exercisable to acquire one Class A Common Share in the capital of the Company (the "Shares") for a period expiring on May 15,2026. The expiry date of the Warrants will be extended to May 15, 2027. However, if, at any time after the Warrant Repricing becomes effective, the closing price of the Shares, as quoted by the Canadian Securities Exchange (the "CSE"), is equal to or greater than $0.25 per Share for 10 consecutive trading days, the expiration date of the Warrants will automatically be accelerated to the date that is 30 calendar days after the date of such 10 consecutive trading day period. Under the policies of the CSE, the proposed Warrant Repricing is subject to the unanimous consent of the registered holders of the outstanding Warrants. If the Warrant Repricing is approved by holders of the Warrants, it is expected that replacement Warrant certificates will not be issued and that notice of the amendment will be sent to holders of the Warrants. 8% of the Warrants are held by insiders of the Company.

About Nirvana Life Sciences Nirvana Life Sciences Inc. (CSE:NIRV) is an innovator in the emerging non-addictive addictions treatment space. At Nirvana, we believe that traditional medicines can play a leading role in reducing the impacts of the opioids crisis and build healthier communities. For more information visit https://nirvanalifescience.com/

For further information: Bruce Clark CEO info@nirvanalifescience.com Phone: 604-401-8100

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

Forward-Looking Statements This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as "forward-looking statements") within the meaning of Canadian securities laws including, without limitation, statements with respect to the future investments by the Company. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward- looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward- looking statements will not occur. Although the Company believes that the expectations reflected in the forward-looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company's actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.

© 2026 Canjex Publishing Ltd. All rights reserved.